Hello, chalu2, yes, I am still holding. I believe IMUL is still sitting on ~$40MM cash [this is a conservative guesstimate, including the $6MM it is going to invest in Cantab.] It seems that Dr Marr is indeed persuiting the strategy I have envisioned more than a year ago when it decided to get radically change the focus of the co. It seems that he has been executing the script by conserving cash, and farm out the full blown development to others and concentrating on the discovery, feasibility and viability of new drugs. Obviously, this is a conjecture on my part, as I ve no contact whatsoever with the co. I would like to see some confirmation, like a new NDA or another grant on do some feasibility study.
The good thing is that IMUL has been hedging all of its portfolio by converting them into intellectual properties. The down side is that if the other *partners* would have to work fast. All in all, it is probably *cheaper* to bring a drug to market outside of the US [due to the stenuous FDA tests.]
Btw, does anyone know anthing about the Gamma? GABA used as an seizure drug [outside US.] Evidently, someone here in the US has been thinking of using it as an narcotic vaccine also.
best, Bosco |
